Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Securities Class Action

Securities fraud litigation history and active cases

Active Cases

1

Pending Settlement

0

Closed

0

Total Settlement

$0

ARS Pharmaceuticals, Inc. (SPRY) Class Action Lawsuit (August 2026)Active

3:26-cv-04469 • August 5, 2026

Class Period Start

March 9, 2026

Class Period End

June 24, 2026

PSLRA Deadline

October 5, 2026

Case Allegations

10b5

Statutes of Repose

Mar 9, 2029

Country

United States

Court

Federal Court

Docket History

Aug 5, 2026

First Filed Complaint

TOP